Dose Ranging Study of an Ocular Sirolimus (Rapamycin) Formulation in Patients With Diabetic Macular Edema

This study has been completed.

Sponsor:

Collaborator:

MacuSight, Inc.

Information provided by (Responsible Party):

Santen Inc.

ClinicalTrials.gov Identifier:

NCT00656643

First received: April 4, 2008

Last updated: January 8, 2013

Last verified: July 2010

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	May 2012
Primary Completion Date:	November 2009 (Final data collection date for primary outcome measure)